Laurence Quéguiner

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet et al. · Journal of Medicinal Chemistry · 2008 · 100 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Minisci-Photoredox-Mediated α-Heteroarylation of N-Protected Secondary Amines: Remarkable Selectivity of Azetidines

Cyril Bosset, Hélène Beucher, Guillaume Bretel et al. · Organic Letters · 2018 · 74 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains

Céline Mordant, Benoît Schmitt, Élisabeth Pasquier et al. · European Journal of Medicinal Chemistry · 2006 · 70 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units

Peter J. Choi, Hamish S. Sutherland, Amy S.T. Tong et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate, Part 1:  Improving the Pharmacokinetic Profile Using the Structure−Property Relationship

Jean‐François Bonfanti, Frédéric Doublet, Jérôme Fortin et al. · Journal of Medicinal Chemistry · 2007 · 51 citations

Pharmacy, Pharmacokinetics, Pharmacology +16